
As OneCare Winds Down, Vermont Looks AHEAD
In its final operational year, OneCare Vermont said it is committed to supporting its participant network in achieving shared cost and quality goals
In its final operational year, OneCare Vermont said it is committed to supporting its participant network in achieving shared cost and quality goals
The public health community can circle the wagons and complain about the attacking forces outside. Alternatively, public health advocates can take a hard look in the mirror, get outside of their bubble, frankly identify failures and missteps, and determine how to regain the trust of an increasingly skeptical public. The post Public Health’s Proudest Moment…
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Cybersecurity experts predict cybersecurity attacks will continue to happen with more sophistication
President-elect Donald Trump recently appointed former Paypal executive David Sacks as the White House’s first-ever czar for AI and cryptocurrency. Ryan Tarzy — CEO of Avandra Imaging, a federated network for de-identified imaging data — thinks this appointment could help accelerate the pace of innovation in the healthcare industry. The post Why One Startup CEO…
Corxel Pharmaceuticals has acquired an oral small molecule GLP-1 agonist with potential applications in obesity and diabetes. The Phase 2-ready pill could compete with oral metabolic meds in development by companies such as Roche, AstraZeneca, and Structure Therapeutics. The post The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender appeared first on…
Bill Hall, 71, has been fighting for his life for 38 years. These days, he’s feeling worn out. Hall contracted HIV, the virus that can cause AIDS, in 1986. Since then, he’s battled depression, heart disease, diabetes, non-Hodgkin lymphoma, kidney cancer, and prostate cancer. This past year, Hall has been hospitalized five times with dangerous…
Several healthcare provisions, including drug reforms, were left out of the government funding bill, angering some healthcare leaders. The post Healthcare Leaders Slam Exclusion of Key Healthcare Provisions in Spending Package appeared first on MedCity News.
Sotyktu, which became the first TYK2 inhibitor to reach the market after its 2022 FDA approval in plaque psoriasis, now has positive data from two pivotal tests in psoriatic arthritis. Bristol Myers Squibb is trying to add new indications for the drug and stay ahead of competitors including Takeda Pharmaceutical. The post Bristol Myers Squibb’s…
Ascension’s May cyberattack compromised 5.6 million patients’ personal and health information, including Social Security numbers, credit card numbers and addresses. However, there is no evidence that any data was stolen from Acension’s EHR or other clinical systems, the health system said. The post 5.6 Million Patients’ Data Stolen During Ascension’s Ransomware Attack Earlier This Year…